Veterinary Vaccines Market Worth USD 11.3 Billion by 2025 | Leading Companies are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), and Virbac SA (France)

According to the new market research report "Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2025", published by MarketsandMarkets(TM), analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

The global Veterinary Vaccines Market is projected to grow at a CAGR of 7.2% during the forecast period to reach USD 11.3 billion by 2025 from USD 8.0 billion in 2020.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233&utm_source=OpenPr&utm_medium=referral&utm_campaign=paidpr

Factors such as the rising incidence of zoonotic diseases, growth in the companion animal population, initiatives by various government agencies and animal associations to maintain animal health, and the increasing demand for animal-derived food products are driving the growth of this market.

The live attenuated vaccines segment accounted for the largest share of the veterinary vaccines market.

Based on technology, the veterinary vaccines market is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccines. The live attenuated vaccines segment accounted for the largest share of the veterinary vaccines market in 2019, majorly due to the ease of administration and long-term immunity offered by these vaccines.

Browse in-depth TOC on "Veterinary Vaccines Market"
238 - Tables
25 - Figures
180 - Pages
Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1233&utm_source=OpenPr&utm_medium=referral&utm_campaign=paidpr

The porcine circovirus II segment accounted for the largest share of the porcine vaccines market in 2019.

Based on disease, the porcine vaccines market is segmented into porcine reproductive and respiratory syndrome (PRRS), porcine circovirus II, porcine parvovirus, swine influenza, swine pneumonia, and other porcine diseases. In 2019, the porcine circovirus II segment dominated this market owing to the high and growing prevalence of the infection

North America to dominate the neuromodulation market during the forecast period

In 2019, North America dominated the veterinary vaccines market, followed by Europe. The major factors driving the growth of this market include the increasing animal population, growing animal disease prevalence, rising awareness on veterinary vaccines, and the high and increasing demand for animal products in the region.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1233&utm_source=OpenPr&utm_medium=referral&utm_campaign=paidpr

Key Players

The prominent players in this market include Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (US), Virbac (France), Vetoquinol (France), Phibro Animal Health (US), Hester Biosciences (India), HIPRA (Spain), Biogenesis Bago (Argentina), Tianjin Ringpu (China), China Animal Husbandry (China), Jinyu Biotechnology (China), and Endovac Animal Health (US).

Contact Us
Mr. Aashish Mehra
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets(TM)
MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's(TM) flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.